Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids

被引:39
作者
Jun, SW [1 ]
Kim, MS [1 ]
Jo, GH [1 ]
Lee, S [1 ]
Woo, JS [1 ]
Park, JS [1 ]
Hwang, SJ [1 ]
机构
[1] Chungnam Natl Univ, Coll Pharm, Natl Res Lab Pharmaceut Technol, Taejon 305764, South Korea
关键词
D O I
10.1211/jpp.57.12.0003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cefuroxime axetil (CA) solid dispersions with HPMC 2910/PVP K-30 were prepared using solution enhanced dispersion by supercritical fluids (SEDS) in an effort to increase the dissolution rate of poorly water-soluble drugs. Their physicochemical properties in solid state were characterized by differential scanning calorimeter (DSC), powder X-ray diffraction (PXRD), Fourier transform infrared spectrometry (FT-IR) and scanning electron microscopy. No endothermic and characteristic diffraction peaks corresponding to CA were observed for the solid dispersions in DSC and PXRD. FTIR analysis demonstrated the presence of intermolecular hydrogen bonds between CA and HPMC 2910/PVP K-30 in solid dispersions, resulting in the formation of amorphous or non-crystalline CA. Dissolution studies indicated that the dissolution rates were remarkably increased in solid dispersions compared with those in the physical mixture and drug alone. In conclusion, an amorphous or non-crystalline CA solid dispersion prepared using SEDS could be very useful for the formulation of solid dosage forms.
引用
收藏
页码:1529 / 1537
页数:9
相关论文
共 38 条
[1]   Control of the physical form of salmeterol xinofoate [J].
Beach, S ;
Latham, D ;
Sidgwick, C ;
Hanna, M ;
York, P .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (05) :370-376
[2]   Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer [J].
Chattopadhyay, P ;
Gupta, RB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 228 (1-2) :19-31
[3]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[4]   The mechanisms of drug release from solid dispersions in water-soluble polymers [J].
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :131-144
[5]  
Crisp H., 1989, Patent, Patent No. 4820833
[6]  
CRISP HA, 1985, Patent No. 4562181
[7]   CEFUROXIME AXETIL [J].
DELLAMONICA, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1994, 4 (01) :23-36
[8]   Polymorphic properties of micronized carbamazepine produced by RESS [J].
Gosselin, PM ;
Thibert, R ;
Preda, M ;
McMullen, JN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) :225-233
[9]  
HANNA M, 1993, Patent No. 93136422
[10]   Evaluation of solid dispersion particles prepared with SEDS [J].
Juppo, AM ;
Boissier, C ;
Khoo, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (02) :385-401